Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Lupin LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500257NSE Symbol: LUPINP/E(TTM):35.73
ISIN Demat:INE326A01037Div & Yield %:0.25EPS(TTM):45.22
Book Value(Rs):422.9660038Market Cap ( Cr.):73642.38Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 11258.8311771.6711055.9311025.6611356.3210088.18
Excise Duty0.000.000.000.000.007.60
Net Sales11258.8311771.6711055.9311025.6611356.3210080.58
Other Income 210.02216.99129.09475.19291.34131.12
Stock Adjustments -120.79242.3881.8628.72147.23-84.67
Total Income11348.0612231.0411266.8811529.5711794.8910127.03
EXPENDITURE :      
Raw Materials 4676.904709.644264.174235.994040.133389.68
Power & Fuel Cost447.42418.45389.54416.26416.30381.32
Employee Cost 1934.141918.161695.861703.221515.421441.64
Other Manufacturing Expenses 1155.601209.091135.791108.701050.871194.38
Selling and Administration Expenses 1797.131573.221355.011557.701488.581416.04
Miscellaneous Expenses 162.951976.35253.36884.11479.4586.99
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure10174.1411804.919093.739905.988990.757910.05
Operating Profit1173.92426.132173.151623.592804.142216.98
Interest 98.4473.4740.6252.5935.4733.24
Gross Profit1075.48352.662132.531571.002768.672183.74
Depreciation548.34514.19502.83518.75426.30389.81
Profit Before Tax527.14-161.531629.701052.252342.371793.93
Tax95.8957.80362.85362.05795.00386.57
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax6.04-30.638.23-37.358.5462.70
Reported Net Profit425.21-188.701258.62727.551538.831344.66
Extraordinary Items 14.4230.6441.61-425.63-205.1530.93
Adjusted Net Profit410.79-219.341217.011153.181743.981313.73
Adjst. below Net Profit -1.392.42-7.89-135.66-46.47-68.97
P & L Balance brought forward15032.7415514.1014535.2514227.3412961.0612024.18
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 181.85295.08271.88226.30226.08338.81
P & L Balance carried down15274.7115032.7415514.1014592.9314227.3412961.06
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %200.00200.00325.00300.00250.00250.00
Earnings Per Share-Unit Curr9.35-4.1527.7416.0634.0129.74
Earnings Per Share(Adj)-Unit Curr9.35-4.1527.7416.0634.0129.74
Book Value-Unit Curr404.66399.34409.20385.72378.28349.15